This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1987 Apr;11(2):233-40.

doi: 10.1007/BF01656407.

Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis

D L Dunn

PMID: 3296482
DOI: 10.1007/BF01656407

Review

Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis

D L Dunn. World J Surg. 1987 Apr.

. 1987 Apr;11(2):233-40.

doi: 10.1007/BF01656407.

Author

D L Dunn

PMID: 3296482
DOI: 10.1007/BF01656407

No abstract available

PubMed Disclaimer

Similar articles

Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection.
Dunn DL, Ewald DC, Chandan N, Cerra FB. Dunn DL, et al. Arch Surg. 1986 Jan;121(1):58-62. doi: 10.1001/archsurg.1986.01400010064008. Arch Surg. 1986. PMID: 3942500
Novel immunotherapeutic approaches to the treatment of infections caused by Gram-negative bacteria.
Palliyil S, Broadbent ID. Palliyil S, et al. Curr Opin Pharmacol. 2009 Oct;9(5):566-70. doi: 10.1016/j.coph.2009.07.007. Epub 2009 Aug 31. Curr Opin Pharmacol. 2009. PMID: 19726227 Review.
Anti-lipopolysaccharide antibodies in gram-negative bacteremia.
Baumgartner JD. Baumgartner JD. Behring Inst Mitt. 1991 Feb;(88):216-21. Behring Inst Mitt. 1991. PMID: 2049041 Review.
Immunological intervention in endotoxin shock.
Ziegler EJ. Ziegler EJ. Prog Clin Biol Res. 1988;272:319-25. Prog Clin Biol Res. 1988. PMID: 3293079 Clinical Trial. No abstract available.
Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
Talan DA. Talan DA. Ann Emerg Med. 1993 Dec;22(12):1871-90. doi: 10.1016/s0196-0644(05)80417-2. Ann Emerg Med. 1993. PMID: 8239111 Review.

See all similar articles

Cited by

Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms.
Burd RS, Battafarano RJ, Cody CS, Farber MS, Ratz CA, Dunn DL. Burd RS, et al. Ann Surg. 1993 Sep;218(3):250-9; discussion 259-61. doi: 10.1097/00000658-199309000-00004. Ann Surg. 1993. PMID: 8373268 Free PMC article.

References

1. Am Rev Respir Dis. 1977 Aug;116(2):241-9 - PubMed
1. Ann Surg. 1984 Mar;199(3):286-91 - PubMed
1. Ann N Y Acad Sci. 1966 Jun 30;133(2):727-45 - PubMed
1. Bacteriol Rev. 1974 Mar;38(1):87-110 - PubMed
1. J Infect Dis. 1977 Aug;136 Suppl:S161-6 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

GM 32414/GM/NIGMS NIH HHS/United States

LinkOut - more resources

Medical
- MedlinePlus Health Information